Inventor · Edison, NJ, US

Mary Struthers

12Patents

3h-index

8Co-inventors

45Inventor score

Filing activity: May 24, 2018 → Feb 14, 2024

Most-cited inventions

Patent	Title	Area	Cited by	Status
US10787494B2	Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use	Emerging Cross-Sectional Technologies	6	Active
US11220550B2	Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity	Chemistry; Metallurgy	5	Active
US11254750B2	Antagonistic CD40 monoclonal antibodies and uses in treating immune responses	Chemistry; Metallurgy	3	Active
US11359000B2	Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use	Emerging Cross-Sectional Technologies	3	Active
US11773178B2	Antagonistic CD40 monoclonal antibodies and uses thereof	Chemistry; Metallurgy	2	Active
US11261258B2	Antagonistic CD40 monoclonal antibodies and uses thereof	Chemistry; Metallurgy	2	Active
US11795231B2	Antagonistic CD40 monoclonal antibodies and uses thereof	Chemistry; Metallurgy	2	Active
US11613585B2	Nucleic acids encoding antagonistic CD40 monoclonal antibodies	Chemistry; Metallurgy	2	Active
US11926673B2	Antagonistic CD40 monoclonal antibodies and uses thereof	Chemistry; Metallurgy	2	Active
US12202872B2	Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use	Emerging Cross-Sectional Technologies	0	Active
US12419953B2	Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies	Chemistry; Metallurgy	0	Active
US12409223B2	Antagonistic CD40 monoclonal antibodies and uses thereof	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.